
CDC advisory panel votes to recommend Pfizer COVID-19 boosters for those 65 and older, or considered high-risk
The Centers for Disease Control and Prevention’s independent advisory panel has unanimously voted to recommend booster doses of Pfizer’s COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months